Dryocrassin ABBA
CAS: 12777-70-7
Ref. 3D-FD73873
1mg | Descontinuado | ||
2mg | Descontinuado | ||
5mg | Descontinuado | ||
10mg | Descontinuado | ||
25mg | Descontinuado |
Informação sobre produto
- 2,5-Cyclohexadien-1-one, 2,2'-(methylenebis((2,4,6-trihydroxy-5-(1-oxobutyl)-3,1-phenylene)methylene)bis(6-acetyl-3,5-dihydroxy-
- 4,4'-{Methanediylbis[(5-Butanoyl-2,4,6-Trihydroxybenzene-3,1-Diyl)Methanediyl]}Bis(2-Acetyl-3,5-Dihydroxy-6,6-Dimethylcyclohexa-2,4-Dien-1-One)
Dryocrassin ABBA is a combination of the herbal extracts dryocarpus and ligustrum and cimicifuga foetida. Dryocarpus is used in traditional Chinese medicine to treat cancer, while ligustrum is used for treating cancer and prostate cancer cells. Cimicifuga foetida has been shown to have an anti-tumor effect on prostate cancer cells by inducing apoptosis via signal pathways. The chemical structures of the compounds in this product are unknown, but it has been shown that they have hemolytic activity and induce apoptosis in prostate cancer cells.